申请人:Janssen Pharmaceutica, N.V.
公开号:US07427625B2
公开(公告)日:2008-09-23
The present invention is directed to substituted thiatriazaacenaphthylene-6-carbonitrile compounds of formula (I):
and forms thereof, their synthesis and use for treating, preventing or ameliorating a chronic or acute protein kinase mediated disease, disorder or condition.
本发明涉及公式(I)的取代的硫杂杂芴-6-碳腈化合物及其衍生物,它们的合成和用于治疗、预防或改善慢性或急性蛋白激酶介导的疾病、紊乱或条件的用途。